Massachusetts Clinical Trial Management
Exam question with correct answers (100%
verified answers) plus rationales Q &A
2026 INSTANT DOWNLOAD PDF
1. What is the primary purpose of clinical trial management?
A. Marketing new drugs
B. Ensuring ethical, efficient trial conduct
C. Increasing pharmaceutical profits
D. Eliminating regulatory oversight
Answer: B
Rationale: Clinical trial management ensures trials are conducted ethically, safely,
and in compliance with regulations.
2. Which document governs ethical conduct in clinical trials?
A. HIPAA
B. Declaration of Helsinki
C. OSHA guidelines
D. FDA Form 1572
Answer: B
Rationale: The Declaration of Helsinki outlines ethical principles for medical
research involving human subjects.
,3. What does GCP stand for?
A. General Clinical Procedures
B. Good Clinical Practice
C. Global Compliance Policy
D. Government Clinical Program
Answer: B
Rationale: GCP is an international ethical and scientific quality standard for trials.
4. Who is responsible for ensuring informed consent is obtained?
A. Sponsor
B. Investigator
C. FDA
D. IRB only
Answer: B
Rationale: The investigator ensures participants give informed consent before
participation.
5. What is the role of an IRB?
A. Drug approval
B. Ethical review of studies
C. Funding trials
D. Manufacturing drugs
Answer: B
Rationale: IRB ensures protection of human subjects in research.
6. What phase evaluates safety in a small group of healthy volunteers?
, A. Phase I
B. Phase II
C. Phase III
D. Phase IV
Answer: A
Rationale: Phase I focuses on safety and dosage.
7. Phase II trials primarily assess:
A. Marketing strategy
B. Efficacy and side effects
C. Drug manufacturing
D. Post-market surveillance
Answer: B
Rationale: Phase II evaluates effectiveness and adverse reactions.
8. Phase III trials are designed to:
A. Test in animals
B. Confirm efficacy in large populations
C. Develop protocols
D. Replace Phase I
Answer: B
Rationale: Phase III involves large-scale testing to confirm effectiveness.
9. Phase IV trials occur:
A. Before human testing
B. After drug approval
C. During animal studies
D. Only in labs
Exam question with correct answers (100%
verified answers) plus rationales Q &A
2026 INSTANT DOWNLOAD PDF
1. What is the primary purpose of clinical trial management?
A. Marketing new drugs
B. Ensuring ethical, efficient trial conduct
C. Increasing pharmaceutical profits
D. Eliminating regulatory oversight
Answer: B
Rationale: Clinical trial management ensures trials are conducted ethically, safely,
and in compliance with regulations.
2. Which document governs ethical conduct in clinical trials?
A. HIPAA
B. Declaration of Helsinki
C. OSHA guidelines
D. FDA Form 1572
Answer: B
Rationale: The Declaration of Helsinki outlines ethical principles for medical
research involving human subjects.
,3. What does GCP stand for?
A. General Clinical Procedures
B. Good Clinical Practice
C. Global Compliance Policy
D. Government Clinical Program
Answer: B
Rationale: GCP is an international ethical and scientific quality standard for trials.
4. Who is responsible for ensuring informed consent is obtained?
A. Sponsor
B. Investigator
C. FDA
D. IRB only
Answer: B
Rationale: The investigator ensures participants give informed consent before
participation.
5. What is the role of an IRB?
A. Drug approval
B. Ethical review of studies
C. Funding trials
D. Manufacturing drugs
Answer: B
Rationale: IRB ensures protection of human subjects in research.
6. What phase evaluates safety in a small group of healthy volunteers?
, A. Phase I
B. Phase II
C. Phase III
D. Phase IV
Answer: A
Rationale: Phase I focuses on safety and dosage.
7. Phase II trials primarily assess:
A. Marketing strategy
B. Efficacy and side effects
C. Drug manufacturing
D. Post-market surveillance
Answer: B
Rationale: Phase II evaluates effectiveness and adverse reactions.
8. Phase III trials are designed to:
A. Test in animals
B. Confirm efficacy in large populations
C. Develop protocols
D. Replace Phase I
Answer: B
Rationale: Phase III involves large-scale testing to confirm effectiveness.
9. Phase IV trials occur:
A. Before human testing
B. After drug approval
C. During animal studies
D. Only in labs
